S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
NASDAQ:HEPA

Hepion Pharmaceuticals (HEPA) Earnings Date, Estimates & Call Transcripts

$4.60
-0.22 (-4.56%)
(As of 04:25 PM ET)
Compare
Today's Range
$4.51
▼
$4.98
50-Day Range
$4.82
▼
$9.76
52-Week Range
$4.51
▼
$23.85
Volume
37,683 shs
Average Volume
143,761 shs
Market Capitalization
$17.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

HEPA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HEPA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Hepion Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20231($2.94)($2.94)($2.94)
Q3 20231($2.65)($2.65)($2.65)
Q4 20231($2.84)($2.84)($2.84)

HEPA Earnings Date and Information

Hepion Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 2nd, 2023 based off prior year's report dates.

Hepion Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/2/2023
Estimated)		------- 
11/14/2022Q3 2022-($2.20)($2.20)($0.11)--
8/15/2022Q2 2022-($5.20)($5.20)($0.26)--
5/16/2022Q1 2022-($1.80)($1.80)($0.09)--
4/8/2022Q4 2021-($2.60)($2.60)($0.13)--
11/15/2021Q3 2021-($2.40)($2.40)($0.12)--
8/16/2021Q2 2021-($2.00)($2.00)($0.10)--
5/14/2021Q1 2021-($2.40)($2.40)($0.12)--
11/15/2020Q3($10.20)($13.80)($3.60)($0.69)--












Hepion Pharmaceuticals Earnings - Frequently Asked Questions

When is Hepion Pharmaceuticals's earnings date?

Hepion Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 2nd, 2023 based off last year's report dates. Learn more on HEPA's earnings history.

How much profit does Hepion Pharmaceuticals generate each year?

Hepion Pharmaceuticals (NASDAQ:HEPA) has a recorded net income of -$42.20 million. HEPA has generated -$11.80 earnings per share over the last four quarters.

What is Hepion Pharmaceuticals's EPS forecast for next year?

Hepion Pharmaceuticals's earnings are expected to grow from ($8.99) per share to ($6.36) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:HEPA) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -